Company Overview of Intrexon Corporation
Intrexon Corporation, a biotechnology company, operates in the synthetic biology field. Synthetic biology is a discipline that applies engineering principles to biological systems. The company designs, builds, and regulates gene programs, which are DNA sequences that consist of key genetic components using its proprietary and complementary technologies. Its proprietary and complementary technologies comprise UltraVector gene design and fabrication platform, which is an integrated suite of tools comprising DNA construction technology and components, cellular and protein engineering tools, computational models, and statistical methods; Cell systems informatics, a bioinformatics software and da...
222 Lakeview Avenue
West Palm Beach, FL 33401
Founded in 1998
Key Executives for Intrexon Corporation
Founder and Chief Science Officer
Total Annual Compensation: $499.2K
Chief Operating Officer
Total Annual Compensation: $2.1M
Senior Vice President of Energy & Chemicals Sector and President of Industrial Products Division
Total Annual Compensation: $341.0K
Executive Vice President of Scientific & Public Affairs
Total Annual Compensation: $485.3K
Compensation as of Fiscal Year 2013.
Intrexon Corporation Key Developments
Intrexon Names Christopher Basta Vice President of Investor Relations
May 19 14
Intrexon Corporation announced the appointment of Christopher Basta as Vice President of Investor Relations, effective immediately. Mr. Basta will report directly to Chairman and Chief Executive Officer Randal J. Kirk. Mr. Basta brings more than 18 years of financial experience to Intrexon. Most recently, he was a consultant for DSP Group directing its investor relations initiatives.
Intrexon Corporation Presents at World Congress on Industrial Biotechnology, May-12-2014
May 9 14
Intrexon Corporation Presents at World Congress on Industrial Biotechnology, May-12-2014 . Venue: Philadelphia, Pennsylvania, United States.
Intrexon Corporation Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2014
May 7 14
Intrexon Corporation announced unaudited consolidated earnings results for the first quarter ended March 31, 2014. For the quarter, the company reported net income attributable to Intrexon of $4.1 million, or $0.04 per basic and diluted share compared to net loss attributable to Intrexon of $36.3 million or $7.54 basic and diluted for the quarter ended March 31, 2013. Adjusted EBITDA was $17.6 million, or $0.18 per basic and diluted share compared to adjusted LBITDA of $7.0 million or $0.09 per basic and diluted share for the quarter ended March 31, 2013. Total revenues were $7.9 million compared to $3.9 million for the quarter ended March 31, 2013, an increase of $4.0 million, or 102.2%. Operating loss was $17.872 million against $14.006 million a year ago. Income before tax was $3.555 million against loss before tax of $36.362 million a year ago. Net income attributable to common shareholders was $4.115 million against net loss attributable to common shareholders of $42.716 million a year ago. EBITDA was $6.218 million against LBITDA of $34.429 million a year ago.
Similar Private Companies By Industry
Recent Private Companies Transactions